MedPath

Metoclopramide Versus Ketorolac for Tension-type Headache

Phase 4
Completed
Conditions
Headache
Interventions
Registration Number
NCT01011673
Lead Sponsor
Montefiore Medical Center
Brief Summary

Occasionally, episodic tension-type headache may be severe enough to require an emergency department (ED) visit. The purpose of this study is to compare two commonly used medications to see which is better for tension type headache. Patients who present to the ED with an acute tension-type headache requiring treatment with injectable medication will be randomized to metoclopramide or ketorolac.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
123
Inclusion Criteria
  • Acute tension type headache
Exclusion Criteria
  • Contraindications to investigational medications
  • Secondary cause of headache

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
KetorolacKetorolacKetorolac 30mg IVSS
MetoclopramideMetoclopramidemetoclopramide 20mg IVSS + diphenhydramine 25mg IVSS
Primary Outcome Measures
NameTimeMethod
Change in Pain ScoreBaseline, 60 minutes

At baseline at at 60 minutes, all patients were asked to describe their pain on a scale from 0 to 10, with 0 representing no pain and 10 the worst imaginable. The primary outcome is the 60 minute score subtracted from the baseline score

Secondary Outcome Measures
NameTimeMethod
Satisfaction Scores24 hours

24 hours after the emergency department visit, patients were asked, "The next time you come to the Er with this type of headache, do you want to receive the same medication?" Affirmative answers are tabulated here.

Trial Locations

Locations (1)

Montefiore Medical Center

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath